Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HSV-Tk |
Trade Name | |
Synonyms | Nalotimagene carmaleucel |
Drug Descriptions |
HSV-Tk (Nalotimagene carmaleucel) is a gene therapy encoding the herpes simplex virus thymidine kinase (HSV-tk), which when introduced together with ganciclovir (GCV), converts GCV to a potent cytotoxic drug that disrupts DNA replication and leads to cell death (PMID: 17327829). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bicalutamide + HSV-Tk + Leuprolide + Valacyclovir | Bicalutamide HSV-Tk Leuprolide Valacyclovir | 0 | 1 |
HSV-Tk | HSV-Tk | 0 | 1 |
HSV-Tk + Valacyclovir | HSV-Tk Valacyclovir | 0 | 1 |